Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Rusnano Corporation, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Rusnano Corporation, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Rusnano Corporation, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Rusnano Corporation, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 2 |
| Rusnano Corporation, Medical Devices Deals, 2010 to YTD 2016 | 11 | 1 |
| Rusnano Corporation, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 12 | 5 |
| Rusnano Corporation, Pharmaceuticals &Healthcare, Deal Details | 17 | 50 |
| Venture Financing | 17 | 1 |
| Solix Biosystems Vostok Raises Funds through Venture Financing | 17 | 1 |
| Tragara Pharma Raises USD13 Million in Series C Financing | 18 | 2 |
| Syndax Pharma Raises USD80 Million in Series C Financing | 20 | 2 |
| Selecta Biosciences Raises More than USD20 Million in Venture Financing | 22 | 2 |
| Clearside Biomedical Raises USD16 Million in Series B Venture Financing | 24 | 2 |
| Aldea Pharma Raises USD24 Million in Series B Venture Financing | 26 | 2 |
| Bioptix Raises USD1.4 Million in Venture Financing | 28 | 1 |
| Epic Sciences Raises USD30 Million in Series C Venture Financing | 29 | 2 |
| NovaDigm Therapeutics Raises US$14 Million In Series B Financing | 31 | 2 |
| Tragara Pharma Raises US$12 Million In Extended Series B Financing | 33 | 2 |
| Syndax Pharma Raises US$27 Million In Series B Venture Financing | 35 | 2 |
| Lithera Raises US$35.6 Million In Series C Financing | 37 | 2 |
| Marinus Pharma Raises US$21 Million In Series C Financing | 39 | 2 |
| Regado Biosciences Raises US$51 Million In Series E Financing | 41 | 2 |
| CoDa Therapeutics Raises Additional US$20 Million In Series B Financing | 43 | 2 |
| Selecta Biosciences Secures US$47 Million In Series D Financing Round | 45 | 2 |
| Bind Biosciences Secures US$35 Million In Series D Financing Round | 47 | 3 |
| Bioptix Diagnostics Raises US$9 Million In Series B Financing | 50 | 1 |
| Partnerships | 51 | 1 |
| Domain Associates Forms Joint Venture With Rusnano | 51 | 1 |
| Rusnano, Human Stem Cells Institute, Pharmsynthez, Cryonix, And FDS Pharma Form SynBio | 52 | 2 |
| RUSNANO Enters Into Joint Venture Agreement With NEARMEDIC PLUS | 54 | 1 |
| Cleveland BioLabs Forms Joint Venture With RUSNANO | 55 | 2 |
| Celtic Pharma Forms Joint Venture With Russian Corporation Of Nanotechnologies | 57 | 2 |
| Rusnano Enters into Joint Venture Agreement with Epidbiomed | 59 | 1 |
| Chemrar Enters Into Joint Venture Agreement With Rusnano | 60 | 1 |
| MP Biomedicals Enters Into Co-Development Agreement With RUSNANO | 61 | 1 |
| MP Biomedicals Enters Into An Agreement With RUSNANO | 62 | 1 |
| Equity Offering | 63 | 1 |
| Farmsintez to Raise USD47.9 Million in Private Placement of Additional Shares | 63 | 1 |
| Farmsintez to Raise USD66.6 Million in Private Placement of Shares | 64 | 1 |
| Acquisition | 65 | 1 |
| Rusnano Acquires Minority Stake In Pharmsynthez For US$26.1 Million | 65 | 1 |
| IPG Photonics Acquires Remaining 22.5% Stake In NTO IRE-Polus From Rusnano For US$55.4 Million | 66 | 1 |
| Rusnano Corporation - Key Competitors | 67 | 1 |
| Key Employees | 68 | 1 |
| Locations And Subsidiaries | 69 | 1 |
| Head Office | 69 | 1 |
| Other Locations &Subsidiaries | 69 | 1 |
| Appendix | 70 | 1 |
| Methodology | 70 | 1 |
| About GlobalData | 70 | 1 |
| Contact Us | 70 | 1 |
| Disclaimer | 70 | 1 |